Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Lyme borreliosis incidence in Lombardy, Italy (2000-2015): Spatiotemporal analysis and environmental risk factors.

Zanzani SA, Rimoldi SG, Manfredi M, Grande R, Gazzonis AL, Merli S, Olivieri E, Giacomet V, Antinori S, Cislaghi G, Bestetti G, Nan K, Sala V, Gismondo MR, Atzori C, De Faveri E.

Ticks Tick Borne Dis. 2019 Oct;10(6):101257. doi: 10.1016/j.ttbdis.2019.07.001. Epub 2019 Jul 3.

PMID:
31285164
2.

Cerebrospinal fluid biomarkers in patients with central nervous system infections: a retrospective study.

Di Stefano A, Alcantarini C, Atzori C, Lipani F, Imperiale D, Burdino E, Audagnotto S, Mighetto L, Milia MG, Di Perri G, Calcagno A.

CNS Spectr. 2019 May 27:1-7. doi: 10.1017/S1092852919000981. [Epub ahead of print]

PMID:
31130152
3.

Is Dolutegravir Plus Atazanavir Overburdened With Concentration-Related Neurological Events Compared With Other Dual Regimens?

Capetti AF, Atzori C, Cossu MV, Ciccullo A, Restelli S, Piscaglia M, Gallazzi I, Meraviglia P, DiGiambenedetto S, Rizzardini G.

Open Forum Infect Dis. 2019 Feb 6;6(2):ofz044. doi: 10.1093/ofid/ofz044. eCollection 2019 Feb. No abstract available.

4.

Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene.

Di Fede G, Catania M, Atzori C, Moda F, Pasquali C, Indaco A, Grisoli M, Zuffi M, Guaita MC, Testi R, Taraglio S, Sessa M, Gusmaroli G, Spinelli M, Salzano G, Legname G, Tarletti R, Godi L, Pocchiari M, Tagliavini F, Imperiale D, Giaccone G.

Acta Neuropathol Commun. 2019 Jan 3;7(1):1. doi: 10.1186/s40478-018-0656-4.

5.

Exact Stoichiometry of Ce xZr6- x Cornerstones in Mixed-Metal UiO-66 Metal-Organic Frameworks Revealed by Extended X-ray Absorption Fine Structure Spectroscopy.

Lomachenko KA, Jacobsen J, Bugaev AL, Atzori C, Bonino F, Bordiga S, Stock N, Lamberti C.

J Am Chem Soc. 2018 Dec 19;140(50):17379-17383. doi: 10.1021/jacs.8b10343. Epub 2018 Dec 7.

PMID:
30497258
6.

Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration.

Piaceri I, Imperiale D, Ghidoni E, Atzori C, Bagnoli S, Ferrari C, Ungari S, Ambrogio L, Sorbi S, Nacmias B.

J Alzheimers Dis. 2018;62(4):1683-1689. doi: 10.3233/JAD-170989.

PMID:
29614680
7.

Unravelling the Redox-catalytic Behavior of Ce4+ Metal-Organic Frameworks by X-ray Absorption Spectroscopy.

Smolders S, Lomachenko KA, Bueken B, Struyf A, Bugaev AL, Atzori C, Stock N, Lamberti C, Roeffaers MBJ, De Vos DE.

Chemphyschem. 2018 Feb 19;19(4):373-378. doi: 10.1002/cphc.201700967. Epub 2017 Nov 15.

PMID:
29027736
8.

Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients.

Salvaggio SE, Giacomelli A, Falvella FS, Oreni ML, Meraviglia P, Atzori C, Clementi EGI, Galli M, Rusconi S.

BMC Infect Dis. 2017 Jun 5;17(1):396. doi: 10.1186/s12879-017-2497-3.

9.

Tailoring adsorption induced phase transitions in the pillared-layer type metal-organic framework DUT-8(Ni).

Kavoosi N, Bon V, Senkovska I, Krause S, Atzori C, Bonino F, Pallmann J, Paasch S, Brunner E, Kaskel S.

Dalton Trans. 2017 Apr 5;46(14):4685-4695. doi: 10.1039/c7dt00015d.

PMID:
28332683
10.

Brain 18F-FDG PET/CT findings in a case of genetic Creutzfeldt-Jakob disease due to V203I heterozygous mutation in the PRNP gene.

Cistaro A, Cassalia L, Ferrara C, Atzori C, Vai D, Quartuccio N, Fania P, Vaudano GP, Imperiale D.

J Neurol. 2017 Jan;264(1):170-173. doi: 10.1007/s00415-016-8327-5. Epub 2016 Nov 14. No abstract available.

PMID:
27844164
11.

Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis.

Calcagno A, Romito A, Atzori C, Ghisetti V, Cardellino C, Audagnotto S, Scarvaglieri E, Lipani F, Imperiale D, Di Perri G, Bonora S.

J Neuroimmune Pharmacol. 2017 Mar;12(1):187-193. doi: 10.1007/s11481-016-9717-2. Epub 2016 Nov 8.

PMID:
27826896
12.

Development and Validation of a Chromatographic Ultraviolet Method for the Simultaneous Quantification of Dolutegravir and Rilpivirine in Human Plasma.

Cozzi V, Charbe N, Baldelli S, Castoldi S, Atzori C, Cattaneo D, Clementi E.

Ther Drug Monit. 2016 Jun;38(3):407-13. doi: 10.1097/FTD.0000000000000290.

PMID:
26885814
13.

Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis.

Trentalange A, Calcagno A, Ghisetti V, Atzori C, Busolli P, Bonora S, Imperiale D.

Antivir Ther. 2016;21(7):633-635. doi: 10.3851/IMP3032. Epub 2016 Feb 9.

PMID:
26857363
14.

Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients.

Calcagno A, Atzori C, Romito A, Vai D, Audagnotto S, Stella ML, Montrucchio C, Imperiale D, Di Perri G, Bonora S.

J Neurovirol. 2016 Feb;22(1):88-92. doi: 10.1007/s13365-015-0371-x. Epub 2015 Aug 6.

PMID:
26246357
15.

A large genomic deletion leads to enhancer adoption by the lamin B1 gene: a second path to autosomal dominant adult-onset demyelinating leukodystrophy (ADLD).

Giorgio E, Robyr D, Spielmann M, Ferrero E, Di Gregorio E, Imperiale D, Vaula G, Stamoulis G, Santoni F, Atzori C, Gasparini L, Ferrera D, Canale C, Guipponi M, Pennacchio LA, Antonarakis SE, Brussino A, Brusco A.

Hum Mol Genet. 2015 Jun 1;24(11):3143-54. doi: 10.1093/hmg/ddv065. Epub 2015 Feb 20.

16.

Cerebrospinal fluid biomarkers in patients with plasma HIV RNA below 20 copies/mL.

Calcagno A, Atzori C, Romito A, Ecclesia S, Imperiale D, Audagnotto S, Alberione MC, Trentalange A, Di Perri G, Bonora S.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19719. doi: 10.7448/IAS.17.4.19719. eCollection 2014.

17.

Diffuse leukoencephalopathy due to lymphomatosis cerebri: a clinicopathological report.

Imperiale D, Taraglio S, Atzori C, Testi R.

Neurol Sci. 2015 Jun;36(6):1071-3. doi: 10.1007/s10072-014-1974-3. Epub 2014 Oct 29. No abstract available.

PMID:
25351342
18.

Quality of life, cortisol blood levels and exercise in older adults: results of a randomized controlled trial.

Mura G, Cossu G, Migliaccio GM, Atzori C, Nardi AE, Machado S, Carta MG.

Clin Pract Epidemiol Ment Health. 2014 Jun 13;10:67-72. doi: 10.2174/1745017901410010067. eCollection 2014.

19.

cART durability and causes for treatment switching or discontinuation in HIV-positive patients older than 50 years of age.

Orlando G, Meraviglia P, Valsecchi L, Mainini A, Schiavini M, Merli S, Cordier L, Angeli E, Giorgi R, Atzori C, Dedivitiis G, Beretta R, Fasolo M, Zampini L, Gubertini G, Fasan M, Zambelli A, Gulisano C, Mazza F, Minisci D, Ricci E, Rizzardini G.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):e12-4. doi: 10.1097/QAI.0b013e3181ef791b. No abstract available.

PMID:
20859084
20.

Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study.

Helweg-Larsen J, Benfield T, Atzori C, Miller RF.

J Antimicrob Chemother. 2009 Dec;64(6):1282-90. doi: 10.1093/jac/dkp372. Epub 2009 Oct 26.

21.

Restriction fragment length polymorphism typing demonstrates substantial diversity among Pneumocystis jirovecii isolates.

Ripamonti C, Orenstein A, Kutty G, Huang L, Schuhegger R, Sing A, Fantoni G, Atzori C, Vinton C, Huber C, Conville PS, Kovacs JA.

J Infect Dis. 2009 Nov 15;200(10):1616-22. doi: 10.1086/644643.

22.

A previously undiagnosed case of Gerstmann-Sträussler-Scheinker disease revealed by PRNP gene analysis in patients with adult-onset ataxia.

Cagnoli C, Brussino A, Sbaiz L, Di Gregorio E, Atzori C, Caroppo P, Orsi L, Migone N, Buffa C, Imperiale D, Brusco A.

Mov Disord. 2008 Jul 30;23(10):1468-71. doi: 10.1002/mds.21953.

PMID:
18566986
23.

Multifocal necrotizing leukoencephalopathy mimicking sporadic Creutzfeldt-Jakob disease.

Imperiale D, Taraglio S, Atzori C, Testi R, Buffa C, Migheli A.

Eur Neurol. 2008;59(6):327-9. doi: 10.1159/000121425. Epub 2008 Apr 11. No abstract available.

24.

Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia: a case series and systematic review.

Benfield T, Atzori C, Miller RF, Helweg-Larsen J.

J Acquir Immune Defic Syndr. 2008 May 1;48(1):63-7. doi: 10.1097/QAI.0b013e31816de84d. Review.

PMID:
18360286
25.

Lack of caspase-dependent apoptosis in spinal motor neurons of the wobbler mouse.

Bigini P, Atzori C, Fumagalli E, Cagnotto A, Barbera S, Migheli A, Mennini T.

Neurosci Lett. 2007 Oct 16;426(2):106-10. Epub 2007 Sep 4.

PMID:
17890007
26.

Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype.

Valerio A, Tronconi E, Mazza F, Fantoni G, Atzori C, Tartarone F, Duca P, Cargnel A.

J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):521-8.

PMID:
17558331
27.

Regression of white matter MRI abnormalities in nonvasculitic autoimmune inflammatory meningoencephalitis following intravenous immunoglobulin.

Imperiale D, Guastamacchia G, Duca S, Appendino L, Marietti G, Romito A, Atzori C, Buffa C.

Eur Neurol. 2007;57(4):244-5. Epub 2007 Mar 26. No abstract available.

28.

The non-peptidic HIV protease inhibitor tipranavir and two synthetic peptidomimetics (TS98 and TS102) modulate Pneumocystis carinii growth and proteasome activity of HEL299 cell line.

Mazza F, Tronconi E, Valerio A, Groettrup M, Kremer M, Tossi A, Benedetti F, Cargnel A, Atzori C.

J Eukaryot Microbiol. 2006;53 Suppl 1:S144-6. No abstract available.

PMID:
17169036
29.

Detection of a proteasome in Pneumocystis carinii and its modulation by specific proteasome inhibitors.

Tronconi E, Mazza F, Valerio A, Rinaudo MT, Piccinini M, Anselmino A, Cargnel A, Atzori C.

J Eukaryot Microbiol. 2006;53 Suppl 1:S142-3. No abstract available.

PMID:
17169035
30.

Detection of HIV protease inhibitors in alveolar epithelial lining fluid: relevance for modulation of pneumocystis infection in the course of HAART.

Atzori C, Villani P, Regazzi M, Mazza F, Valerio A, Tronconi E, Maruzzi M, Cargnel A.

J Eukaryot Microbiol. 2006;53 Suppl 1:S140-1. No abstract available.

PMID:
17169034
31.

DHPS-mutated isolates of Pneumocystis jirovecii from HIV-infected individuals: analysis of related ITS genotypes.

Valerio A, Tronconi E, Mazza F, Cargnel A, Fantoni G, Atzori C.

J Eukaryot Microbiol. 2006;53 Suppl 1:S108-9. No abstract available.

PMID:
17169019
32.

A case of Pneumocystis jiroveci pneumonia in X-linked agammaglobulinaemia treated with immunosuppressive therapy: a lesson for immunologists.

Sirianni MC, Atzori C, De Santis W, Milito C, Esposito A, Marziali M, Bernardi ML, Cargnel A, Aiuti F.

Int Arch Allergy Immunol. 2006;140(1):82-8. Epub 2006 Mar 20.

PMID:
16549936
33.

Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.

Huang L, Crothers K, Atzori C, Benfield T, Miller R, Rabodonirina M, Helweg-Larsen J.

Emerg Infect Dis. 2004 Oct;10(10):1721-8. Review.

34.

Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice.

Bendotti C, Atzori C, Piva R, Tortarolo M, Strong MJ, DeBiasi S, Migheli A.

J Neuropathol Exp Neurol. 2004 Feb;63(2):113-9.

PMID:
14989597
35.

Detection of intrapulmonary concentration of lopinavir in an HIV-infected patient.

Atzori C, Villani P, Regazzi M, Maruzzi M, Cargnel A.

AIDS. 2003 Jul 25;17(11):1710-1. No abstract available.

PMID:
12853760
36.

Assessment of immune reconstitution to Pneumocystis carinii in HIV-1 patients under different highly active antiretroviral therapy regimens.

Atzori C, Clerici M, Trabattoni D, Fantoni G, Valerio A, Tronconi E, Cargnel A.

J Antimicrob Chemother. 2003 Aug;52(2):276-81. Epub 2003 Jul 1.

PMID:
12837736
37.

Molecular mechanisms of neuronal death in the dorsal lateral geniculate nucleus following visual cortical lesions.

Repici M, Atzori C, Migheli A, Vercelli A.

Neuroscience. 2003;117(4):859-67.

PMID:
12654338
38.

Analysis of variation in tandem repeats in the intron of the major surface glycoprotein expression site of the human form of Pneumocystis carinii.

Ma L, Kutty G, Jia Q, Imamichi H, Huang L, Atzori C, Beckers P, Groner G, Beard CB, Kovacs JA.

J Infect Dis. 2002 Dec 1;186(11):1647-54. Epub 2002 Nov 11.

PMID:
12447742
39.

Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein.

Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, Yoshida H, Holzer M, Craxton M, Emson PC, Atzori C, Migheli A, Crowther RA, Ghetti B, Spillantini MG, Goedert M.

J Neurosci. 2002 Nov 1;22(21):9340-51.

40.

Whole-cell Bordetella pertussis vaccine component modulates the mouse immune response to an unrelated soluble antigen.

Lavigne MV, Castro M, Mateo N, Deluchi S, Atzori C, Piudo L, Calcagno M, Brero ML, Manghi M.

Microbes Infect. 2002 Jul;4(8):815-20.

PMID:
12270728
41.

[Cytokines induced by experimental anti-tetanus immunization. Vaccine formulation effect].

Castro M, Mateo N, Lavigne V, Deluchi S, Atzori C, Piudo L, Brero ML, Manghi M.

Medicina (B Aires). 2002;62(2):154-8. Spanish.

PMID:
12038038
42.

Human immunodeficiency virus protease inhibitors and Pneumocystis carinii.

Atzori C, Cargnel A.

J Infect Dis. 2002 Jun 1;185(11):1692-3; author reply 1693-4. No abstract available.

PMID:
12023783
43.

Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.

Ma L, Kovacs JA, Cargnel A, Valerio A, Fantoni G, Atzori C.

J Infect Dis. 2002 May 15;185(10):1530-2. Epub 2002 Apr 30.

PMID:
11992293
44.

Pneumocystis carinii does not induce maturation of human dendritic cells.

Macagno A, Atzori C, Fantoni B, Valerio A, Cargnel A, Groettrup M.

J Eukaryot Microbiol. 2001;Suppl:167S-168S. No abstract available.

PMID:
11906047
45.

PCP occurring in HIV patients under HAART: assessment of specific immunity against P. carinii.

Atzori C, Clerici M, Fantoni G, Valerio A, Trabattoni D, Cargnel A.

J Eukaryot Microbiol. 2001;Suppl:152S. No abstract available.

PMID:
11906037
46.

Pneumocystis carinii ITS typing: doubtful evidence of genotype-related virulence.

Atzori C, Valerio A, Fantoni G, Drago L, Gismondo MR, Cargnel A.

J Eukaryot Microbiol. 2001;Suppl:147S. No abstract available.

PMID:
11906034
47.

Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis.

Atzori C, Ghetti B, Piva R, Srinivasan AN, Zolo P, Delisle MB, Mirra SS, Migheli A.

J Neuropathol Exp Neurol. 2001 Dec;60(12):1190-7.

PMID:
11764091
48.

In vitro activity of amprenavir against Pneumocystis carinii.

Atzori C, Fantoni G, Valerio A, Cargnel A.

Int J Antimicrob Agents. 2001 Sep;18(3):271-3. No abstract available.

PMID:
11708264
49.

Pneumocystis carinii diagnosis: an update.

Agostoni F, Atzori C, Angeli E, Mainini A, Micheli V, Cargnel A.

Int J Antimicrob Agents. 2000 Dec;16(4):549-57.

PMID:
11118878
50.

Defective neurogenesis in citron kinase knockout mice by altered cytokinesis and massive apoptosis.

Di Cunto F, Imarisio S, Hirsch E, Broccoli V, Bulfone A, Migheli A, Atzori C, Turco E, Triolo R, Dotto GP, Silengo L, Altruda F.

Neuron. 2000 Oct;28(1):115-27.

Supplemental Content

Loading ...
Support Center